Chandler says the acquisition complements the agency, strengthens it globally, and generates business opportunities.
"It was a seminal year for us in many ways - with PRWeek recognition [Midsize Agency of the Year]," Chandler says.
Chandler sees a "big internal communications component in pharma industry growth." CCA aims to be the world's go-to healthcare specialist.
In July 2007, inVentiv Health acquired CCA. Headcount is 207, up 10% with 21% turnover. Senior hires include Joe Pessolan, CFO; Sheri Jaffe, senior PR counselor; and Siona Hall, MD of Europe. Chief creative officer Helayne Spivak left the agency.
CCA has three subsidiaries: Brandtectonics (branding); Determinus (research); and 'nition (design).
There are 12 global affiliates, and CCA often works with colleagues in Italy,
Germany, Spain, Korea, and China.
Founding partner Robert Chandler sees a "high-growth year" in London. In the US and Europe, clients are increasing re-quests for integrated services. Growth is expected in consumer health marketing, market access comms, and digital media.
Consumer business is "increasing dramatically," and top-10 pharma companies are awarding business in every category. Chicco reports a 75% win rate.
New wins include Danone and Nutricia. Novartis and Allergan grew organically. Ten wins were across three or more markets. The Roche/GSK Boniva account was lost due to the client's decision to explore other agencies.
Global revenue between $50 million to $100 million, with US revenue less than $50 million. Top and bottom lines grew.
Principals: Robert Chandler (r) and Gianfranco Chicco (l), founding partners; and William O'Donnell, president & COO, inVentiv Health
Ownership: inVentiv Health
Offices: Five - New York (HQ), LA, Washington, DC, London, and Paris